Q2 2025 Management View Robert M. Davis, CEO, highlighted "meaningful progress in delivering our important medicines and vaccines to patients and customers, while advancing our innovative pipeline." ...

It’s going to be over 100 degrees in Houston, Texas today, but Lara Schwartz is intent on not feeling the heat. The rising ...

West Ham United have reportedly made a fresh approach for Cagliari striker Roberto Piccoli, who just completed a permanent ...

The restructuring includes the elimination of certain roles and a reduction in the company’s global real estate footprint.

Daniele Ghilardi is effectively a done deal with Roma, they are just trying to finalise the specifics of the add-ons on top ...

Facing an end to Keytruda's market exclusivity, the company will cut $3 billion in costs that it plans to redeploy in support ...

Daniele Ghilardi is effectively a done deal with Roma, they are just trying to finalise the specifics of the add-ons on top ...

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to persistent weakness in demand for the blockbuster human papillomavirus vaccine, ...

CEO Rob Davis referred to the cost reduction program as a “reallocation” rather than a cut, with the savings to be reinvested ...

Merck stock fell early Tuesday after Q2 results. The Dow Jones drugmaker plans for job cuts as part of restructuring ...

The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster ...